Breast cancer overdiagnosis rates not as high as estimated previously
1. About 1 in 7 cases of screen-detected cancer is overdiagnosed in the US population. 2. The rate...
Read More
Oncology
Postoperative treatment without radioiodine has noninferior outcomes following thyroidectomy
1. Patients with low-risk thyroid cancer undergoing thyroidectomy, who did not receive radioiodine...
Read More
Non-alcoholic fatty liver disease-related hepatocellular carcinoma (HCC) differ clinically compared to HCC due to other causes
1. Patients with NAFLD-related HCC have longer disease-free survival compared to those with HCC...
Read More
Hepatocellular Carcinoma: The Viral Hepatitis Pathways
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and incidence...
Read More
Pertuzumab has clinical benefits in metastatic breast cancer but is not cost-effective
1. The incremental cost-effectiveness ratio of the pertuzumab group was $436,679 per QALY gained....
Read More